Table 4.
Metabolic screening
| Alpha-1 globulins (g/L) | 2 (2–4) |
| Alpha-2 globulins (g/L) | 11 (5–9) |
| Beta globulins (g/L) | 8 (6–10) |
| Gamma globulins (g/L) | 14 (8–16) |
| QEP | No paraprotein detected |
| Free kappa (mg/L) | 60.3 (3.3–19.4) |
| Free lambda (mg/L) | 29.8 (5.7–26.3) |
| Kappa to lambda ratio | 2.02 |
| IgA (g/L) | 5.87 (0.6–3.4) |
| IgG (g/L) | 12.2 (5.8–13.7) |
| IgM (g/L) | 0.29 (0.3–1.7) |
| HbA1c | 6.4% |
| Ferritin (mg/L) | 205 (30–620) |
| Iron (mmol/L) | 19 (9–30) |
| Transferrin (mmol/L) | 31 (23–43) |
| Transferrin saturation | 31% (14%–45%) |
| Cholesterol (mmol/L) | 3.5 |
| Triglycerides (mmol/L) | 1.7 |
| Parathyroid hormone (pmol/L) | 3.6 (1.6–9.0) |
| TSH (mU/L) | 0.99 (0.4–4) |
| Free T4 (pmol/L) | 14 (9–19) |
| INR | 1.0 |
| APTT (s) | 31.9 (27.5–38.5) |
| Fibrinogen (g/L) | 4.9 (2–4) |
| Albumin (g/L) | 36 (35–50) |
| Globulins (g/L) | 32 (25–42) |
| Bilirubin (mmol/L) | 17 (<20) |
| ALT (U/L) | 25 (<40) |
| ALP (U/L) | 100 (30–110) |
| GGT (U/L) | 121 (<60) |
ALP, Alkaline phosphatase; ALT, Alanine aminotransferase; APTT, Activated partial thromboplastin time; GGT, Gamma-glutamyl transferase; HbA1c, Glycated haemoglobin; INR, Internal normalised ratio; QEP, Quantitative protein electrophoresis; TSH, Thyroid stimulating hormone.